A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease. (2022)
Attributed to:
Gene therapy for CLN5 Batten disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-022-17338-1
PubMed Identifier: 35970890
Publication URI: http://europepmc.org/abstract/MED/35970890
Type: Journal Article/Review
Volume: 12
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322